Please assess the completion status of the following clinical trial:

Trial Title: Evolution of Neuropathies Associated With Necrotizing Vasculitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Adult patient with an initial diagnosis or a relapse of :~- Systemic Vasculitic Neuropathy (SVN): Primary Necrotizing Vasculitis answering the Chapel Hill Consensus Conference criteria associated with a symptomatic Vasculitic Peripheral Neuropathy~Or~- Non Systemic Vasculitic Neuropathy (NSVN): pure symptomatic peripheral neurological impairment without systemic visceral impairment~Exclusion Criteria:~* Symptomatic peripheral neurological impairment not attributable exclusively to primary necrotizing vasculitis~* Diabetes~* Chronic ethylism~* AL (immunoglobulin light chain) amyloidosis or TTR (transthyretin)~* Genetic neuropathies~* Toxic neuropathies~* Sequelae of sciatica~* Opposition to participation in the study~* Lack of social security~* Under guardianship or curatorship

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Study Arms:
- Necrotizing Vasculitis (Type: None): Patient with an initial diagnosis or a relapse of :~- Systemic Vasculitic Neuropathy (SVN): Primary Necrotizing Vasculitis answering the Chapel Hill Consensus Conference criteria associated with a symptomatic Vasculitic Peripheral Neuropathy~Or~- Non Systemic Vasculitic Neuropathy (NSVN): pure symptomatic peripheral neurological impairment without systemic visceral impairment

Based on this trial design, predict the completion outcome and termination type (if applicable).